정자수 검사 시장 규모, 점유율, 동향 분석 보고서 : 기술별, 용도별, 제품별, 지역별, 부문별 예측(2026-2033년)

Sperm Count Test Market Summary

The global sperm count test market size was estimated at USD 362.39 million in 2025 and is projected to reach USD 559.89 million by 2033, growing at a CAGR of 5.65% from 2026 to 2033. This growth is attributed to the rising prevalence of male infertility, growing awareness about reproductive health, and the importance of early fertility assessment among men.

In addition, delayed parenthood and changing social trends have increased the demand for fertility evaluations as couples seek medical assistance to conceive. Moreover, increased availability of fertility clinics, supportive government initiatives for reproductive health, and higher healthcare spending in both developed and emerging economies continue to propel demand for sperm count tests.

Global Sperm Count Test Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global sperm count test market report based on product, technology, end use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Clinical Semen Analyzer Systems (CASA / Automated Analyzers)
• At-Home Sperm Count Test Kits
• Smartphone-Enabled Sperm Count Devices
• Mail-In Sperm Count Test Kits
• Others
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Manual Microscopy
• Computer-Assisted Sperm Analysis (CASA)
• Microfluidics-Based Counting
• Smartphone-Enabled Imaging
• Spectrophotometric / Colorimetric
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Fertility Clinics
• Home Care Settings
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1 Market Segmentation & Scope
• 1.2 Segment Definitions
  • 1.2.1 Product
  • 1.2.2 Technology
  • 1.2.2 End Use
• 1.3 Research Methodology
  • 1.3.1 Commodity flow analysis
  • 1.3.2 Information procurement
    • 1.3.2.1 Purchased database
    • 1.3.2.2 GVR's internal database
    • 1.3.2.3 Primary research
• 1.4 Information or Data Analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation & Validation
• 1.6 List of Secondary Sources
• 1.7 List of Abbreviations
• 1.8 Objectives

Chapter 2. Executive Summary

• 2.1 Market Snapshot
• 2.2 Market Segmentation
• 2.4 Competitive Landscape

Chapter 3. Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Analysis
  • 3.2.2 Market Restraint Analysis
  • 3.2.3 Market Opportunity Analysis
  • 3.2.4 Market Challenge Analysis
• 3.3 Industry Analysis Tools
  • 3.3.1 Porter's Five Forces Analysis
  • 3.3.2 PESTLE Analysis

Chapter 4. Sperm Count Test Market: Product Estimates & Trend Analysis

• 4.1 Sperm Count Test Market: Product Segment Dashboard
• 4.2 Product Movement & Market Share Analysis, 2025 & 2033
• 4.3 Global Sperm Count Test Market Size Estimates & Forecast, by Product
  • 4.3.1 Clinical Semen Analyzer Systems (CASA / Automated Analyzers)
    • 4.3.1.1 Clinical Semen Analyzer Systems (CASA / Automated Analyzers) Market, 2021 - 2033 (USD Million)
  • 4.3.2 At-Home Sperm Count Test Kits
    • 4.3.2.1 At-Home Sperm Count Test Kits Market, 2021 - 2033 (USD Million)
  • 4.3.3 Smartphone-Enabled Sperm Count Devices
    • 4.3.3.1 Smartphone-Enabled Sperm Count Devices Market, 2021 - 2033 (USD Million)
  • 4.3.4 Mail-In Sperm Count Test Kits
    • 4.3.4.1 Mail-In Sperm Count Test Kits Market, 2021 - 2033 (USD Million)
  • 4.3.5 Others
    • 4.3.5.1 Others Market, 2021 - 2033 (USD Million)

Chapter 5. Sperm Count Test Market: Technology Estimates & Trend Analysis

• 5.1 Sperm Count Test Market: Technology Segment Dashboard
• 5.2 Technology Movement & Market Share Analysis, 2025 & 2033
• 5.3 Global Sperm Count Test Market Size Estimates & Forecast, by Technology
  • 5.3.1 Manual Microscopy
    • 5.3.1.1 Manual Microscopy Market, 2021 - 2033 (USD Million)
  • 5.3.2 Computer-Assisted Sperm Analysis (CASA)
    • 5.3.2.1 Computer-Assisted Sperm Analysis (CASA) Market, 2021 - 2033 (USD Million)
  • 5.3.3 Microfluidics-Based Counting
    • 5.3.3.1 Microfluidics-Based Counting Market, 2021 - 2033 (USD Million)
  • 5.3.4 Smartphone-Enabled Imaging
    • 5.3.4.1 Smartphone-Enabled Imaging Market, 2021 - 2033 (USD Million)
  • 5.3.5 Spectrophotometric / Colorimetric
    • 5.3.5.1 Spectrophotometric / Colorimetric Market, 2021 - 2033 (USD Million)

Chapter 6. Sperm Count Test Market: End Use Estimates & Trend Analysis

• 6.1 Sperm Count Test Market: End Use Segment Dashboard
• 6.2 End Use Movement & Market Share Analysis, 2026 & 2033
• 6.3 Global Sperm Count Test Market Size Estimates & Forecast, by End Use
  • 6.3.1 Hospitals
    • 6.3.1.1 Hospitals Market, 2021 - 2033 (USD Million)
  • 6.3.2 Fertility Clinics
    • 6.3.2.1 Fertility Clinics Market, 2021 - 2033 (USD Million)
  • 6.3.3 Home Care Settings
    • 6.3.3.1 Home Care Settings Market, 2021 - 2033 (USD Million)
  • 6.3.4 Others
    • 6.3.4.1 Others Market, 2021 - 2033 (USD Million)

Chapter 7. Sperm Count Test Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2025 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. Canada
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Mexico
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Europe
  • 7.5.1. UK
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. France
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. Italy
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. Spain
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Norway
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Regulatory framework
    • 7.5.8.3. Competitive scenario
    • 7.5.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. India
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.4. Australia
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Singapore market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Argentina
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.8. MEA
  • 7.8.1. South Africa
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.8.3. UAE
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory framework
    • 7.8.4.3. Competitive scenario
    • 7.8.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Key company market position analysis, 2025
• 8.4. List of Companies
  • 8.4.1. Medical Electronic Systems
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Hamilton Thorne
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Merck KGaA
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. MICROPTIC
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. ExSeed Health.
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Proiser R+D (ARQUIMEA Agrotech)
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. DNA Diagnostics Center (DDC)
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Sperm Processor
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Genea BIOMEDX
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. LogixX Pharma Limited UK
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives